EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII)

María Esperanza Guirao García, Pedro Marín Rodríguez, Carmen María Servet Pérez de Lema, Noel Blaya Boluda, Pilar Sánchez Henarejos, Miguel Ángel Moya Hernández, Andrea Gottlob Pérez, Caridad Marín Hernández, Pilar de la Morena Barrio, Elisa García Garre, Elena García-Martínez, Francisco Ayala de la Peña und 2 weitere

Breast Cancer Research and Treatment · 2026

DOI: 10.1007/s10549-026-07928-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2026. Verfasst von María Esperanza Guirao García und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital Universitario Morales Meseguer, 30008, Murcia, Spain. Hauptthemen laut MEDLINE: Neutrophils, Breast Neoplasms, Lymphocytes, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Calasparra se mueve", “Pulseras solidarias", Universidad de Murcia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the potential prognostic value of two peripheral immune biomarkers—neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII)—in breast cancer patients treated with neoadjuvant chemotherapy, and to assess their association with pathological complete response (pCR) and other predictive factors. In addition, to determine whether prognostic or predictive differences exist between baseline and post-neoadjuvant values of these biomarkers.

Methods

We analyzed 801 women with early breast cancer treated with neoadjuvant chemotherapy, evaluating clinical and pathological data, survival outcomes, NLR (continuous and categorical) and SII.

Results

Baseline NLR was significantly higher in younger patients, in those with positive pathological nodes, and in the HER2 + /HR − subtype, while baseline SII was elevated in the triple-negative subtype. Post-neoadjuvant chemotherapy (post-NCT) NLR and SII showed only weak associations with estrogen receptor expression, yet both were independently associated with pCR (post-NCT NLR: OR = 0.91; 95% CI: 0.84–0.98; p = 0.02; post-NCT SII: OR = 0.65; 95% CI: 0.47–0.89; p = 0.008). Neither biomarker showed a significant impact on overall or progression-free survival.

Conclusion

Post-treatment NLR and SII may reflect chemotherapy-induced immune changes and are associated with pathological complete response, but their additional predictive value is uncertain, and no prognostic impact was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsBreast NeoplasmsLymphocytesBiomarkers, TumorInflammationHumansFemaleNeoadjuvant TherapyPrognosisMiddle AgedPathologic Complete ResponseAdultAgedAntineoplastic Combined Chemotherapy ProtocolsLymphocyte Count

Stichwörter der Autor:innen

Complete pathological responseEarly breast cancerNeutrophil-to-lumphocyte ratioPrognosisSystemic immune inflammation index

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Hospital Universitario Morales Meseguer, 30008, Murcia, Spain.
  • Department of Medicine, Medical School, University of Murcia, 30001, Murcia, Spain.
  • Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, 30120, Murcia, Spain.
  • Department of General and Digestive Surgery, Hospital Universitario Virgen de La Arrixaca, 30120, Murcia, Spain.
  • Department of Gynecology. Hospital, Universitario Virgen de La Arrixaca, 30120, Murcia, Spain.
  • Department of Medical Oncology, Hospital Universitario Virgen de La Arrixaca, 30120, Murcia, Spain.

Förderung

  • "Calasparra se mueve"
  • “Pulseras solidarias"
  • Universidad de Murcia

Zitieren

APA

Guirao García, M. E., Marín Rodríguez, P., Servet Pérez de Lema, C. M., Blaya Boluda, N., Sánchez Henarejos, P., Moya Hernández, M. Á., Gottlob Pérez, A., Marín Hernández, C., de la Morena Barrio, P., García Garre, E., García-Martínez, E., Ayala de la Peña, F., Piñero Madrona, A., & García-Torralba, E. (2026). Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-07928-2

Vancouver

Guirao García ME, Marín Rodríguez P, Servet Pérez de Lema CM, Blaya Boluda N, Sánchez Henarejos P, Moya Hernández MÁ, et al. Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII). Breast Cancer Research and Treatment. 2026. doi:10.1007/s10549-026-07928-2

BibTeX
@article{GuiraoGarca2026,
  author = {Guirao García, María Esperanza and Marín Rodríguez, Pedro and Servet Pérez de Lema, Carmen María and Blaya Boluda, Noel and Sánchez Henarejos, Pilar and Moya Hernández, Miguel Ángel and Gottlob Pérez, Andrea and Marín Hernández, Caridad and de la Morena Barrio, Pilar and García Garre, Elisa and García-Martínez, Elena and Ayala de la Peña, Francisco and Piñero Madrona, Antonio and García-Torralba, Esmeralda},
  title = {Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII)},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  doi = {10.1007/s10549-026-07928-2}
}
Kostenlos starten →